Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma

Hematol Oncol. 2019 Dec;37(5):634-637. doi: 10.1002/hon.2685. Epub 2019 Oct 28.

Affiliations

¹ Second Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital, Athens, Greece.
² Second Department of Pathology, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 31657017
DOI: 10.1002/hon.2685

No abstract available

Publication types

Letter

MeSH terms

Disease Management
Female
Humans
Incidence
Lymphoma, Large B-Cell, Diffuse / complications*
Lymphoma, Large B-Cell, Diffuse / diagnosis
Lymphoma, Large B-Cell, Diffuse / epidemiology*
Lymphoma, Large B-Cell, Diffuse / therapy
Male
Paraproteinemias / complications*
Paraproteinemias / diagnosis
Paraproteinemias / epidemiology
Patient Outcome Assessment
Prognosis
Public Health Surveillance
Rituximab / administration & dosage
Rituximab / adverse effects
Rituximab / therapeutic use

Substances

Rituximab